Shore Capital Partners has invested in Argentum Medical LLC, a maker of wound care products, and certain assets of Cura Surgical Inc. using capital from the firm’s Shore Capital Partners Fund I. Financial terms of the growth investment were not disclosed.
Argentum marks the seventh platform investment from Fund I. The June 2014 fund raised nearly $112.5 millionin committed capital. Geneva, Illinois-based Argentum manufactures antimicrobial burn care, wound care, and surgical products such as: adhesive bandages, adhesive strips, tubular digit sleeves, wound contact dressings, drain tubes, and fixator pins. The target distributes products, including those under the Silverlon brand, to consumers and medical professionals across the U.S., Europe, Italy, Spain, Portugal, France, Greece, Switzerland and South Africa. Fund I typically invests between $10 million and $15 million per platform.